FDA Orange Book
Generic for Ceclor
Ceclor contains cefaclor. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Ceclor is cefaclor. 1 company holds an active FDA approval (ANDA) for a generic version in the Orange Book.
Run it in Rivvi
Map Ceclor and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Ceclor products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| capsule, oral | EQ 250MG BASE | Discontinued | None | 1 | None |
| capsule, oral | EQ 500MG BASE | Discontinued | None | 1 | None |
| for suspension, oral | EQ 125MG BASE/5ML | Discontinued | None | 1 | None |
| for suspension, oral | EQ 250MG BASE/5ML | Discontinued | None | 1 | None |
NDA 050521, 050522, held by ELI LILLY AND CO. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic cefaclor
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTD | 065146 | None (No TE code listed) | January 22, 2004 | EQ 250MG BASE, EQ 500MG BASE |
| YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTD | 065412 | None (No TE code listed) | February 17, 2012 | EQ 125MG BASE/5ML, EQ 250MG BASE/5ML |
Questions
Is there a generic for Ceclor?
Yes. The generic name for Ceclor is cefaclor. 1 company holds an active FDA approval (ANDA) for a generic version in the Orange Book.
What is the generic name for Ceclor?
The active ingredient in Ceclor is cefaclor, per the FDA Orange Book.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.